223 related articles for article (PubMed ID: 26641553)
1. Genetic Variants and Systemic Complement Activation Levels Are Associated With Serum Lipoprotein Levels in Age-Related Macular Degeneration.
Paun CC; Ersoy L; Schick T; Groenewoud JM; Lechanteur YT; Fauser S; Hoyng CB; de Jong EK; den Hollander AI
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7766-73. PubMed ID: 26641553
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum lipid concentrations and genetic variants at high-density lipoprotein metabolism loci and TIMP3 in age-related macular degeneration.
Fauser S; Smailhodzic D; Caramoy A; van de Ven JP; Kirchhof B; Hoyng CB; Klevering BJ; Liakopoulos S; den Hollander AI
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5525-8. PubMed ID: 21613373
[TBL] [Abstract][Full Text] [Related]
3. Association of high-density lipoprotein and apolipoprotein E genetic variants with age-related macular degeneration.
Cezario SM; Calastri MC; Oliveira CI; Carmo TS; Pinhel MA; Godoy MF; Jorge R; Cotrim CC; Souza DR; Siqueira RC
Arq Bras Oftalmol; 2015; 78(2):85-8. PubMed ID: 25945528
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration.
Lorés-Motta L; Paun CC; Corominas J; Pauper M; Geerlings MJ; Altay L; Schick T; Daha MR; Fauser S; Hoyng CB; den Hollander AI; de Jong EK
Ophthalmology; 2018 Jul; 125(7):1064-1074. PubMed ID: 29398083
[TBL] [Abstract][Full Text] [Related]
5. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
[TBL] [Abstract][Full Text] [Related]
6. Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor study.
Cougnard-Grégoire A; Delyfer MN; Korobelnik JF; Rougier MB; Le Goff M; Dartigues JF; Barberger-Gateau P; Delcourt C
PLoS One; 2014; 9(3):e90973. PubMed ID: 24608419
[TBL] [Abstract][Full Text] [Related]
7. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
[TBL] [Abstract][Full Text] [Related]
8. Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration.
Reynolds R; Rosner B; Seddon JM
Ophthalmology; 2010 Oct; 117(10):1989-95. PubMed ID: 20888482
[TBL] [Abstract][Full Text] [Related]
9. Correlation between serum lipids and age-related macular degeneration: a case-control study.
Davari MH; Gheitasi H; Yaghobi G; Heydari B
J Res Health Sci; 2013 May; 13(1):98-101. PubMed ID: 23772022
[TBL] [Abstract][Full Text] [Related]
10. Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels.
Ristau T; Paun C; Ersoy L; Hahn M; Lechanteur Y; Hoyng C; de Jong EK; Daha MR; Kirchhof B; den Hollander AI; Fauser S
PLoS One; 2014; 9(3):e93459. PubMed ID: 24675670
[TBL] [Abstract][Full Text] [Related]
11. Mendelian Randomization Implicates High-Density Lipoprotein Cholesterol-Associated Mechanisms in Etiology of Age-Related Macular Degeneration.
Burgess S; Davey Smith G
Ophthalmology; 2017 Aug; 124(8):1165-1174. PubMed ID: 28456421
[TBL] [Abstract][Full Text] [Related]
12. Changes in lipid metabolism in women with age-related macular degeneration.
Nowak M; Swietochowska E; Marek B; Szapska B; Wielkoszynski T; Kos-Kudla B; Karpe J; Kajdaniuk D; Sieminska L; Glogowska-Szelag J; Nowak K
Clin Exp Med; 2005 Mar; 4(4):183-7. PubMed ID: 15750765
[TBL] [Abstract][Full Text] [Related]
13. Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology Consortia.
Colijn JM; den Hollander AI; Demirkan A; Cougnard-Grégoire A; Verzijden T; Kersten E; Meester-Smoor MA; Merle BMJ; Papageorgiou G; Ahmad S; Mulder MT; Costa MA; Benlian P; Bertelsen G; Bron AM; Claes B; Creuzot-Garcher C; Erke MG; Fauser S; Foster PJ; Hammond CJ; Hense HW; Hoyng CB; Khawaja AP; Korobelnik JF; Piermarocchi S; Segato T; Silva R; Souied EH; Williams KM; van Duijn CM; Delcourt C; Klaver CCW; ;
Ophthalmology; 2019 Mar; 126(3):393-406. PubMed ID: 30315903
[TBL] [Abstract][Full Text] [Related]
14. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration.
Saksens NT; Lechanteur YT; Verbakel SK; Groenewoud JM; Daha MR; Schick T; Fauser S; Boon CJ; Hoyng CB; den Hollander AI
PLoS One; 2016; 11(6):e0144367. PubMed ID: 27258093
[TBL] [Abstract][Full Text] [Related]
16. Systemic complement activation in age-related macular degeneration.
Scholl HP; Charbel Issa P; Walier M; Janzer S; Pollok-Kopp B; Börncke F; Fritsche LG; Chong NV; Fimmers R; Wienker T; Holz FG; Weber BH; Oppermann M
PLoS One; 2008 Jul; 3(7):e2593. PubMed ID: 18596911
[TBL] [Abstract][Full Text] [Related]
17. The effects of eight serum lipid biomarkers on age-related macular degeneration risk: a Mendelian randomization study.
Han X; Ong JS; Hewitt AW; Gharahkhani P; MacGregor S
Int J Epidemiol; 2021 Mar; 50(1):325-336. PubMed ID: 33211829
[TBL] [Abstract][Full Text] [Related]
18. Integrating Metabolomics, Genomics, and Disease Pathways in Age-Related Macular Degeneration: The EYE-RISK Consortium.
Acar İE; Lores-Motta L; Colijn JM; Meester-Smoor MA; Verzijden T; Cougnard-Gregoire A; Ajana S; Merle BMJ; de Breuk A; Heesterbeek TJ; van den Akker E; Daha MR; Claes B; Pauleikhoff D; Hense HW; van Duijn CM; Fauser S; Hoyng CB; Delcourt C; Klaver CCW; Galesloot TE; den Hollander AI;
Ophthalmology; 2020 Dec; 127(12):1693-1709. PubMed ID: 32553749
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: a possible role in glucocorticoid deficiency.
Spadaro L; Noto D; Privitera G; Tomaselli T; Fede G; Scicali R; Piro S; Fayer F; Altieri I; Averna M; Purrello F
Scand J Gastroenterol; 2015 Mar; 50(3):347-54. PubMed ID: 25592451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
